SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Evelo Biosciences Q1 EPS $(0.710) Beats $(0.750) Estimate

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.710) per share which beat the analyst consensus estimate of $(0.750) by 5.33 percent. This is a 10.94 percent decrease over losses of $(0.640) per share

Benzinga · 05/11/2020 11:17

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.710) per share which beat the analyst consensus estimate of $(0.750) by 5.33 percent. This is a 10.94 percent decrease over losses of $(0.640) per share from the same period last year.